KEDANSIL Trademark

Trademark Overview

On Thursday, December 20, 2012, a trademark application was filed for KEDANSIL with the United States Patent and Trademark Office. The USPTO has given the KEDANSIL trademark a serial number of 85807907. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 30, 2023. This trademark is owned by AstraZeneca AB. The KEDANSIL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
kedansil

General Information

Serial Number85807907
Word MarkKEDANSIL
Filing DateThursday, December 20, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 30, 2023
Registration Number5102650
Registration DateTuesday, December 20, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, June 30, 2023CANCELLED SEC. 8 (6-YR)
Monday, December 20, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 20, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, October 4, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 31, 20161(B) BASIS DELETED; NEW BASIS REQUESTED
Wednesday, August 31, 2016NOTICE OF ALLOWANCE CANCELLED
Friday, August 26, 2016PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, August 25, 2016ASSIGNED TO PETITION STAFF
Monday, August 8, 2016TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, June 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 28, 2016SOU EXTENSION 5 GRANTED
Thursday, June 9, 2016SOU EXTENSION 5 FILED
Thursday, June 9, 2016TEAS EXTENSION RECEIVED
Tuesday, January 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2016SOU EXTENSION 4 GRANTED
Tuesday, December 22, 2015SOU EXTENSION 4 FILED
Tuesday, December 22, 2015TEAS EXTENSION RECEIVED
Friday, June 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 25, 2015SOU EXTENSION 3 GRANTED
Tuesday, June 9, 2015SOU EXTENSION 3 FILED
Tuesday, June 9, 2015TEAS EXTENSION RECEIVED
Friday, February 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 19, 2015SOU EXTENSION 2 GRANTED
Tuesday, January 6, 2015SOU EXTENSION 2 FILED
Tuesday, February 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 6, 2015TEAS EXTENSION RECEIVED
Thursday, July 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 1, 2014SOU EXTENSION 1 GRANTED
Tuesday, July 1, 2014SOU EXTENSION 1 FILED
Tuesday, July 1, 2014TEAS EXTENSION RECEIVED
Tuesday, January 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 17, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 17, 2013ASSIGNED TO LIE
Wednesday, October 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 26, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 8, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 8, 2013NON-FINAL ACTION E-MAILED
Monday, April 8, 2013NON-FINAL ACTION WRITTEN
Monday, April 8, 2013ASSIGNED TO EXAMINER
Tuesday, January 8, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 24, 2012NEW APPLICATION ENTERED

Related Keywords

kedansil diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal